[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements",
    "summary": "The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key earnings and labor market data.",
    "url": "https://finnhub.io/api/news?id=81e90e37656c8ff4307bc156208c4aa536c0d9e8f0db5fd0450f18fdf71ee7ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738618950,
      "headline": "S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements",
      "id": 132574532,
      "image": "https://www.investopedia.com/thmb/W5gf3IhDEUUcIbBOXvmw9FoN_Nc=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/INV_ModernaSign_GettyImages-1288670274-2f734a7a31a74107b40c480d9b2906cc.jpg",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key earnings and labor market data.",
      "url": "https://finnhub.io/api/news?id=81e90e37656c8ff4307bc156208c4aa536c0d9e8f0db5fd0450f18fdf71ee7ff"
    }
  },
  {
    "ts": null,
    "headline": "Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High",
    "summary": "Idexx Laboratories handily beat Wall Street's fourth-quarter expectations Monday, and Idexx stock gapped up to a four-month high.",
    "url": "https://finnhub.io/api/news?id=80d75babb0429ecb5a0e5994bc17ea19694a054c5e1870ca41fc6dc6c3bb658d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738616573,
      "headline": "Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High",
      "id": 132711918,
      "image": "https://media.zenfs.com/en/ibd.com/6c26281518f16dee4dab56aa728c2562",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Idexx Laboratories handily beat Wall Street's fourth-quarter expectations Monday, and Idexx stock gapped up to a four-month high.",
      "url": "https://finnhub.io/api/news?id=80d75babb0429ecb5a0e5994bc17ea19694a054c5e1870ca41fc6dc6c3bb658d"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Constellation Brands, IDEXX, Tyson Foods, and More",
    "summary": "U.S. equities slumped at midday, but were off their lows after President Trump paused new tariffs on Mexico.",
    "url": "https://finnhub.io/api/news?id=da904cec2956a6189d23431631b9f43b666ddc24ccdaa8576a6fcc39f6e49fa6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738601503,
      "headline": "Top Stock Movers Now: Constellation Brands, IDEXX, Tyson Foods, and More",
      "id": 132711919,
      "image": "https://www.investopedia.com/thmb/2-JLEuXcLkXZn9F5bX8v5eYpX2s=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-1910383099-322767129c6e4a8c9713dd01aa1a2571.jpg",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "U.S. equities slumped at midday, but were off their lows after President Trump paused new tariffs on Mexico.",
      "url": "https://finnhub.io/api/news?id=da904cec2956a6189d23431631b9f43b666ddc24ccdaa8576a6fcc39f6e49fa6"
    }
  },
  {
    "ts": null,
    "headline": "Idexx Soars 10.5% After Crushing Q4 Estimates -- Big Buybacks and New Cancer Test Drive 2025 Outlook",
    "summary": "Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.",
    "url": "https://finnhub.io/api/news?id=fbe771c5f7587e45ec6454e89a3fea80a1638e6fe258d5f718a414dcead6b921",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738600950,
      "headline": "Idexx Soars 10.5% After Crushing Q4 Estimates -- Big Buybacks and New Cancer Test Drive 2025 Outlook",
      "id": 132711920,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/20d06a4752d4cedda6496ba4b79dba76",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.",
      "url": "https://finnhub.io/api/news?id=fbe771c5f7587e45ec6454e89a3fea80a1638e6fe258d5f718a414dcead6b921"
    }
  },
  {
    "ts": null,
    "headline": "Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers.",
    "summary": "Idexx Laboratories  stock was rising sharply Monday, even as the  and major indexes remained in the red.  The  rebounded some 500 points after President Donald Trump halted his plans for 25% tariffs on imports from Mexico for a month.  Shares of  Idexx Laboratories  were up 12% on Monday and on track for the largest same-day percentage increase since Nov. 10, 2022, according to Dow Jones Market Data.",
    "url": "https://finnhub.io/api/news?id=eba424bdf3bc932ffda20c4023f1c7179009657db72e4ba4fc1fac85426f6465",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738600260,
      "headline": "Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers.",
      "id": 132711921,
      "image": "https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Idexx Laboratories  stock was rising sharply Monday, even as the  and major indexes remained in the red.  The  rebounded some 500 points after President Donald Trump halted his plans for 25% tariffs on imports from Mexico for a month.  Shares of  Idexx Laboratories  were up 12% on Monday and on track for the largest same-day percentage increase since Nov. 10, 2022, according to Dow Jones Market Data.",
      "url": "https://finnhub.io/api/news?id=eba424bdf3bc932ffda20c4023f1c7179009657db72e4ba4fc1fac85426f6465"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices",
    "summary": "IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.",
    "url": "https://finnhub.io/api/news?id=ad3a8f4988fdbbb1227676efecbe8d25f0eb1e23f57cbeb73ffdee89eaa99069",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738598700,
      "headline": "IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices",
      "id": 132711922,
      "image": "https://www.investopedia.com/thmb/8xRqTHu7OL276uxAuJWOqIUHmr4=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2189110478-19c6e54a7f2643f3bf42fb23f5b4735b.jpg",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.",
      "url": "https://finnhub.io/api/news?id=ad3a8f4988fdbbb1227676efecbe8d25f0eb1e23f57cbeb73ffdee89eaa99069"
    }
  },
  {
    "ts": null,
    "headline": "Why IDXX Is Soaring Today",
    "summary": "Pet healthcare firm Idexx (IDXX) is jumping 10% after delivering better-than-expected fourth-quarter financial results. The midpoint of the company’s 2025 earnings per share guidance range also came in above analysts’ average outlook. Idexx’s Q4 Results and Its 2025 Guidance The company’s Q4 sales rose 5.8% versus the same period a year earlier to $954 million. […]",
    "url": "https://finnhub.io/api/news?id=a00fd5e2c5471fb69a60f8d221e860c8b93541020728cc0a123ded86ca2828f6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738598094,
      "headline": "Why IDXX Is Soaring Today",
      "id": 132711923,
      "image": "https://s.yimg.com/ny/api/res/1.2/ikONL9zPOKV5naBl.isbpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/b5ee69f6db67b9c44e92597291bdbf62",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Pet healthcare firm Idexx (IDXX) is jumping 10% after delivering better-than-expected fourth-quarter financial results. The midpoint of the company’s 2025 earnings per share guidance range also came in above analysts’ average outlook. Idexx’s Q4 Results and Its 2025 Guidance The company’s Q4 sales rose 5.8% versus the same period a year earlier to $954 million. […]",
      "url": "https://finnhub.io/api/news?id=a00fd5e2c5471fb69a60f8d221e860c8b93541020728cc0a123ded86ca2828f6"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?",
    "summary": "IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 million, beating the consensus of $934.99 million, up 6% on a reported and organic basis in the fourth quarter, driven by Companion Animal Group (CAG) growth of 6% as reported and organically to $870.47 million. CAG Diagnostics recurring revenue gains of 6% reported and 7% organic in the quarter were support",
    "url": "https://finnhub.io/api/news?id=06c5d8e9c32b3336c23a618bc09c5414cb0e7a02e1b047013d5fba53302bc306",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738594287,
      "headline": "Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?",
      "id": 132711924,
      "image": "https://media.zenfs.com/en/Benzinga/bf1e7b0008f7dbf284e0486fa7c27c6f",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 million, beating the consensus of $934.99 million, up 6% on a reported and organic basis in the fourth quarter, driven by Companion Animal Group (CAG) growth of 6% as reported and organically to $870.47 million. CAG Diagnostics recurring revenue gains of 6% reported and 7% organic in the quarter were support",
      "url": "https://finnhub.io/api/news?id=06c5d8e9c32b3336c23a618bc09c5414cb0e7a02e1b047013d5fba53302bc306"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: That Was Fast - U.S. Tariffs On Mexico Delayed",
    "summary": "The delay in U.S. tariffs on Mexico led to a reversal in stock market losses and the U.S. dollar's gains against the peso and loonie.",
    "url": "https://finnhub.io/api/news?id=f31e083f646e72b84c7184483da918398099b50d2cd1411dd03399b14b6c4ffe",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738593420,
      "headline": "Wall Street Lunch: That Was Fast - U.S. Tariffs On Mexico Delayed",
      "id": 132538812,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1089424824/image_1089424824.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "The delay in U.S. tariffs on Mexico led to a reversal in stock market losses and the U.S. dollar's gains against the peso and loonie.",
      "url": "https://finnhub.io/api/news?id=f31e083f646e72b84c7184483da918398099b50d2cd1411dd03399b14b6c4ffe"
    }
  },
  {
    "ts": null,
    "headline": "Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say",
    "summary": "Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=e886cc9969c728b5252a5a4cbbeb27793a397087b75f39fd7f4fa47c7671c7b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738593005,
      "headline": "Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say",
      "id": 132711925,
      "image": "https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=e886cc9969c728b5252a5a4cbbeb27793a397087b75f39fd7f4fa47c7671c7b5"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Q4 Earnings and Revenues Top Estimates, Stock Up in Pre-Market",
    "summary": "IDXX delivers better-than-expected earnings and revenues in the fourth quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=f7f666b0c4452ffc320700123aa935b60c88224d2fc09270378cec078d0e904f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738590780,
      "headline": "IDEXX Q4 Earnings and Revenues Top Estimates, Stock Up in Pre-Market",
      "id": 132711926,
      "image": "https://media.zenfs.com/en/zacks.com/51f0c2cd09522c9a15cba48260e4facf",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDXX delivers better-than-expected earnings and revenues in the fourth quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=f7f666b0c4452ffc320700123aa935b60c88224d2fc09270378cec078d0e904f"
    }
  },
  {
    "ts": null,
    "headline": "Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates",
    "summary": "Idexx (IDXX) delivered earnings and revenue surprises of 9.17% and 1.87%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=d9032d9cff4935b58423bfde92749829dcb1379f12cec1a73b52d6d77e0494a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738586402,
      "headline": "Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates",
      "id": 132711927,
      "image": "https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Idexx (IDXX) delivered earnings and revenue surprises of 9.17% and 1.87%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=d9032d9cff4935b58423bfde92749829dcb1379f12cec1a73b52d6d77e0494a4"
    }
  },
  {
    "ts": null,
    "headline": "Idexx: Q4 Earnings Snapshot",
    "summary": "The Westbrook, Maine-based company said it had profit of $2.62 per share. The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.40 per share.",
    "url": "https://finnhub.io/api/news?id=f1f44c758860e0e3883a73b241ca7c52f9b6a504aff5d1385f2b8b513e4b0d62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738583210,
      "headline": "Idexx: Q4 Earnings Snapshot",
      "id": 132711928,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "The Westbrook, Maine-based company said it had profit of $2.62 per share. The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.40 per share.",
      "url": "https://finnhub.io/api/news?id=f1f44c758860e0e3883a73b241ca7c52f9b6a504aff5d1385f2b8b513e4b0d62"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript",
    "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...",
    "url": "https://finnhub.io/api/news?id=01d2602cc62aed9f4847dd34dfd989c8b6b8e23895caa88cb6d0188617e3d1fd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738581974,
      "headline": "IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript",
      "id": 132528902,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...",
      "url": "https://finnhub.io/api/news?id=01d2602cc62aed9f4847dd34dfd989c8b6b8e23895caa88cb6d0188617e3d1fd"
    }
  },
  {
    "ts": null,
    "headline": "Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits",
    "summary": "IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to...",
    "url": "https://finnhub.io/api/news?id=cefc45b5c82c15a42b026269ec663d2aee0496bda6341e692764eb10c2aedc9a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738569413,
      "headline": "Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits",
      "id": 132520093,
      "image": "",
      "related": "IDXX",
      "source": "Finnhub",
      "summary": "IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to...",
      "url": "https://finnhub.io/api/news?id=cefc45b5c82c15a42b026269ec663d2aee0496bda6341e692764eb10c2aedc9a"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Futures Drop in Premarket Trading; Watsco B, Oklo Lag",
    "summary": "S&P 500 Futures Drop in Premarket Trading; Watsco B, Oklo Lag",
    "url": "https://finnhub.io/api/news?id=2f941a5f7a710c8a2954e07acf6974c14de810d63542a2bb5810e3d01fa1e7e6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738567800,
      "headline": "S&P 500 Futures Drop in Premarket Trading; Watsco B, Oklo Lag",
      "id": 132531217,
      "image": "",
      "related": "IDXX",
      "source": "MarketWatch",
      "summary": "S&P 500 Futures Drop in Premarket Trading; Watsco B, Oklo Lag",
      "url": "https://finnhub.io/api/news?id=2f941a5f7a710c8a2954e07acf6974c14de810d63542a2bb5810e3d01fa1e7e6"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories : Q4 2024 Earnings Snapshot",
    "summary": "IDEXX Q4 & Full Year 2024 Earnings Highlights Revenue ...",
    "url": "https://finnhub.io/api/news?id=e61ee823216260ff4f5c9f7d5c2b5d81eac3db969b76866433512361c50fdd5d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738565051,
      "headline": "IDEXX Laboratories : Q4 2024 Earnings Snapshot",
      "id": 132519679,
      "image": "",
      "related": "IDXX",
      "source": "Finnhub",
      "summary": "IDEXX Q4 & Full Year 2024 Earnings Highlights Revenue ...",
      "url": "https://finnhub.io/api/news?id=e61ee823216260ff4f5c9f7d5c2b5d81eac3db969b76866433512361c50fdd5d"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results",
    "summary": "Achieves fourth quarter revenue growth of 6% as reported and on an organic basis, driven by CAG Diagnostics recurring revenue growth of 6% reported and 7% organicSolid growth supported by...",
    "url": "https://finnhub.io/api/news?id=bb53ce11e35177dccd4d2b3ba7d1df006f8c3658c92f6165a97b7104fee562e7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738564323,
      "headline": "IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results",
      "id": 132519601,
      "image": "",
      "related": "IDXX",
      "source": "Finnhub",
      "summary": "Achieves fourth quarter revenue growth of 6% as reported and on an organic basis, driven by CAG Diagnostics recurring revenue growth of 6% reported and 7% organicSolid growth supported by...",
      "url": "https://finnhub.io/api/news?id=bb53ce11e35177dccd4d2b3ba7d1df006f8c3658c92f6165a97b7104fee562e7"
    }
  }
]